Skip to content

Dr. Lins - Dr. Dubois: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Dr. Lins - Dr. Dubois

BE 0871.844.215
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€52,517
2024 · €29,534+€22,983
Equity
€687,163
2024 · €634,646+€52,517
Cash
€56,440
2024 · €35,437+€21,004
Balance sheet total
€699,515
2024 · €641,153+€58,362

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€26,124

    up €26,124 (+118%), from €22,124 to €48,248

    of which Trade receivables: +€18,441

  • Cash +€21,004

    up €21,004 (+59.3%), from €35,437 to €56,440

    mainly Net result for the year (+€52,517) and Depreciation (+€3,975)

  • Current investments +€15,140

    up €15,140 (+2.6%), from €575,147 to €590,287

Equity and liabilities
  • Reserves +€51,119

    up €51,119 (+8.3%), from €615,902 to €667,021

Income statement
  • Gross operating margin +€19,976

    up €19,976 (+37.0%), from €53,994 to €73,970

  • Financial income +€3,737

    up €3,737 (+56.7%), from €6,595 to €10,332

  • Depreciation -€1,940

    down €1,940 (-32.8%), from €5,915 to €3,975

  • Taxes +€1,809

    up €1,809 (+8.1%), from €22,243 to €24,052

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €29,534
Gross operating margin +€19,976
Depreciation +€1,940
Other operating charges -€658
Financial income +€3,737
Financial charges -€204
Taxes -€1,809
Result 2025 €52,517
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€36,144
Investment -€15,140
Financing €0
Cash 2024 €35,437
Net result for the year +€52,517
Depreciation +€3,975
Smaller working-capital items -€69
Receivables within one year -€26,124
Trade debts +€2,507
Tax, wage and social debts +€3,338
Current investments -€15,140
Cash 2025 €56,440
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €641,153 €699,515 +€58,362 +9.1%
Fixed assets 21/28 €5,658 €1,684 -€3,975 -70.2%
Tangible fixed assets 22/27 €5,658 €1,684 -€3,975 -70.2%
Furniture and vehicles 24 €2,535 €706 -€1,829 -72.2%
Other tangible fixed assets 26 €3,123 €978 -€2,145 -68.7%
Current assets 29/58 €635,495 €697,832 +€62,337 +9.8%
Amounts receivable after more than one year 29 €608 €626 +€18 +3.0%
Trade receivables 290 €608 €626 +€18 +3.0%
Amounts receivable within one year 40/41 €22,124 €48,248 +€26,124 +118%
Trade receivables 40 €260 €18,701 +€18,441 +7,094%
Other amounts receivable 41 €21,864 €29,548 +€7,684 +35.1%
Current investments 50/53 €575,147 €590,287 +€15,140 +2.6%
Cash at bank and in hand 54/58 €35,437 €56,440 +€21,004 +59.3%
Deferred charges and accrued income 490/1 €2,179 €2,230 +€51 +2.3%
Total equity and liabilities 10/49 €641,153 €699,515 +€58,362 +9.1%
Equity 10/15 €634,646 €687,163 +€52,517 +8.3%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €615,902 €667,021 +€51,119 +8.3%
Distributable reserves 133 €615,902 €667,021 +€51,119 +8.3%
Profit (loss) carried forward 14 €144 €1,542 +€1,398 +968%
Amounts payable 17/49 €6,507 €12,353 +€5,845 +89.8%
Amounts payable within one year 42/48 €6,507 €12,353 +€5,845 +89.8%
Trade debts 44 €401 €2,908 +€2,507 +626%
Suppliers 440/4 €401 €2,908 +€2,507 +626%
Taxes, remuneration and social security 45 €6,107 €9,445 +€3,338 +54.7%
Taxes 450/3 €6,107 €9,445 +€3,338 +54.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,915 €3,975 -€1,940 -32.8%
Other operating charges 640/8 €2,828 €3,486 +€658 +23.3%
Gross operating margin 9900 €53,994 €73,970 +€19,976 +37.0%
Operating profit (loss) 9901 €45,251 €66,509 +€21,259 +47.0%
Financial income 75/76B €6,595 €10,332 +€3,737 +56.7%
Recurring financial income 75 €6,595 €10,332 +€3,737 +56.7%
Financial charges 65/66B €69 €273 +€204 +294%
Recurring financial charges 65 €69 €273 +€204 +294%
Profit (loss) for the period before taxes 9903 €51,777 €76,569 +€24,792 +47.9%
Income taxes 67/77 €22,243 €24,052 +€1,809 +8.1%
Profit (loss) for the period 9904 €29,534 €52,517 +€22,983 +77.8%
Profit (loss) for the period to be appropriated 9905 €29,534 €52,517 +€22,983 +77.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.